Strata Critical Medical closed at $5.26 on Nov 5, up 0.77%, 18.7% below its 52-week closing high. Volume of 1.7M shares was 1.60× its 20-day average (above normal).
Split-adjusted performance: +12.4% over one month, -1.5% over six months, +11.4% over one year.
In the quarter ended Sep 30, 2026, revenue was $74.08M, up 50.3% from a year earlier, with a net margin of -10.3%.
Short interest was 4.5M shares at the Oct 15 settlement, up 4.8% from the prior report (6.5% of float, 5.0 days to cover).